Annals of Translational Medicine · 2020 · 24 citations · 33 references
MedicineOncologyPharmacologyApoptosisCancer PharmacologyChemotherapyApoptosis In CancerApoptosis PharmacologyMitotic InhibitorsOncology PharmacologyAnticancer ActivityAnticancer ChemotherapyAntimalarial AgentsAntimalarial ChemotherapyAntimalarial Drug DevelopmentApoptosis TargetingHematopoietic Disorders
BACKGROUND: Leukemia is characterized by the presence of highly malignant tumors formed in the hematopoietic system. Artesunate (Art), a semi-synthetic derivative of artemisinin, is commonly used as an antimalarial drug and has been proven to possess anticancer potential. METHODS: . The orthotopic xenograft mouse models were established by using KG1a cells in BALB/c athymic nude mice. Tumor weigh was detected. The protein levels of survivin and Ki67 were detected by immunohistochemistry assays. RESULTS: Art induced cell apoptosis and inhibited cell proliferation and stemness in a dose-dependent manner. In the meantime, the results exhibited that Art inhibited the growth and stemness of transplanted tumors via the suppression of the MEK/ERK and PI3K/Akt pathway. CONCLUSIONS: Our present study provides new insights into the mechanisms of Art's anticancer potential in leukemia.
33
Stephen P. Hunger, Xiaomin Lu, Meenakshi Devidas et al. · Journal of Clinical Oncology · 2012 · 1.2K citations · Full text
Medicine, Oncology, Pediatrics +7
Artesunate Induces ROS-Mediated Apoptosis in Doxorubicin-Resistant T Leukemia Cells
Thomas Efferth, Marco Giaisi, Annette Merling et al. · PLoS ONE · 2007 · 255 citations · Full text
Medicine, Oncology, Pharmacology +16
Wei Fang, Tong Zhang, Shu-Chou Deng et al. · Cancer Letters · 2019 · 217 citations
Medicine, Cancer Biology, Oncology +12